European Commission Approves Orencia(R) (Abatacept) In Combination With Methotrexate For Children With Moderate To Severe pJIA

Links shared publicly online about this topic.

  • 1,427
    total visits

European Commission Approves Orencia(R) (Abatacept) In Combination With Methotrexate For Children With Moderate To Severe pJIA

medicalnewstoday.com —

Bristol-myers squibb company (nyse: bmy) announced that on 20 january 2010, the european commission approved orencia® (abatacept) in combination with methotrexate for the treatment of moderate

View full resource at medicalnewstoday.com

Tags: Crohn's Disease Medication, Rheumatoid Arthritis Medication, Children's Health, Rheumatrex, Trexall, Folex PFS, Orencia, Bristol-Myers Squibb

  • Share

Most Recently Shared on January 26, 2010 at 9:10 pm By:

mnt_arthritis MNT Arthritis News

European Commission Approves Orencia(R) (Abatacept) In Combination With Methotrexate For Children With Moderate To Se... http://mnt.to/3wMZ

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

medical_tweets medical_tweets

Advertisement